U.S. Small Molecule Drug Discovery Outsourcing Market Size, Share & Trends Analysis Report By Workflow, By Service, By Therapeutics Area, By End Use, And Segment Forecasts, 2025 - 2033

Table of Contents

Chapter 1. Research Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Workflow
  • 1.2.2. Service
  • 1.2.3. Therapeutics Area
  • 1.2.4. End Use
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information Or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Value chain-based analysis (Model 2)
  • 1.7.3. Multivariate Analysis (Model 3)
• 1.8. List Of Secondary Sources
• 1.9. List Of Abbreviations
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Small Molecule Drug Discovery Outsourcing Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing demand for outsourcing services in drug development
    • 3.2.1.2. Technological advancements in drug discovery
    • 3.2.1.3. Rising shortening time-to-market pressures
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Intellectual property (IP) and data security concerns
    • 3.2.2.2. Limited standardization and reproducibility
• 3.3. Clinical Trials Volume Analysis, (2024)
  • 3.3.1. Total Number Of Clinical Trials By Country
  • 3.3.2. Total Number Of Clinical Trials, By Phase
  • 3.3.3. Total Number Of Clinical Trials, By Study Design
  • 3.3.4. Total Number Of Clinical Trials, By Key Therapeutic Area
• 3.4. Pricing Model Analysis
• 3.5. Technology Landscape
• 3.6. Market Analysis Tools
  • 3.6.1. Porter's Five Forces Analysis
  • 3.6.2. PESTEL by SWOT Analysis

Chapter 4. U.S. Small Molecule Drug Discovery Outsourcing Market: Workflow Estimates & Trend Analysis

• 4.1. U.S. Small Molecule Drug Discovery Outsourcing Market, By Workflow: Segment Dashboard
• 4.2. U.S. Small Molecule Drug Discovery Outsourcing Market, By Workflow: Movement Analysis
• 4.3. U.S. Small Molecule Drug Discovery Outsourcing Market Estimates & Forecasts, By Workflow, 2021 - 2033 (USD Million)
• 4.4. Target Identification & Screening
  • 4.4.1. Target Identification & Screening Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Target Validation & Functional Informatics
  • 4.5.1. Target Validation & Functional Informatics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Lead Identification & Candidate Optimization
  • 4.6.1. Lead Identification & Candidate Optimization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. Preclinical Development
  • 4.7.1. Preclinical Development Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.8. Others
  • 4.8.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Small Molecule Drug Discovery Outsourcing Market: Service Estimates & Trend Analysis

• 5.1. U.S. Small Molecule Drug Discovery Outsourcing Market, By Service: Segment Dashboard
• 5.2. U.S. Small Molecule Drug Discovery Outsourcing Market, By Service: Movement Analysis
• 5.3. U.S. Small Molecule Drug Discovery Outsourcing Market Estimates & Forecasts, By Service, 2021 - 2033 (USD Million)
• 5.4. Chemistry Services
  • 5.4.1. Chemistry Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Biology Services
  • 5.5.1. Biology Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Small Molecule Drug Discovery Outsourcing Market: Therapeutics Area Estimates & Trend Analysis

• 6.1. U.S. Small Molecule Drug Discovery Outsourcing Market, By Therapeutics Area: Segment Dashboard
• 6.2. U.S. Small Molecule Drug Discovery Outsourcing Market, By Therapeutics Area: Movement Analysis
• 6.3. U.S. Small Molecule Drug Discovery Outsourcing Market Estimates & Forecasts, By Therapeutics Area, 2021 - 2033 (USD Million)
• 6.4. Respiratory system
  • 6.4.1. Respiratory System Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Pain and Anesthesia
  • 6.5.1. Pain and Anesthesia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Oncology
  • 6.6.1. Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Ophthalmology
  • 6.7.1. Ophthalmology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.8. Hematology
  • 6.8.1. Hematology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.9. Cardiovascular
  • 6.9.1. Cardiovascular Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.10. Endocrine
  • 6.10.1. Endocrine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.11. Gastrointestinal
  • 6.11.1. Gastrointestinal Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.12. Immunomodulation
  • 6.12.1. Immunomodulation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.13. Anti-infective
  • 6.13.1. Anti-infective Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.14. Central Nervous System
  • 6.14.1. Central Nervous System Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.15. Dermatology
  • 6.15.1. Dermatology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.16. Genitourinary System
  • 6.16.1. Genitourinary System Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Small Molecule Drug Discovery Outsourcing Market: End Use Estimates & Trend Analysis

• 7.1. U.S. Small Molecule Drug Discovery Outsourcing Market, By End Use: Segment Dashboard
• 7.2. U.S. Small Molecule Drug Discovery Outsourcing Market, By End Use: Movement Analysis
• 7.3. U.S. Small Molecule Drug Discovery Outsourcing Market Estimates & Forecasts, By End Use, 2021 - 2033 (USD Million)
• 7.4. Pharmaceutical & Biotechnology companies
  • 7.4.1. Pharmaceutical & Biotechnology companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.5. Academic Institutes
  • 7.5.1. Academic Institutes Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
  • 8.1.1. Market Leaders
  • 8.1.2. Emerging Players
• 8.2. Company Market Share/Assessment Analysis, 2024
• 8.3. Company Profiles
  • 8.3.1. Charles River Laboratories
    • 8.3.1.1. Company Overview
    • 8.3.1.2. Financial Performance
    • 8.3.1.3. Service Benchmarking
    • 8.3.1.4. Strategic Initiatives
  • 8.3.2. Laboratory Corporation of America Holdings (Covance)
    • 8.3.2.1. Company Overview
    • 8.3.2.2. Financial Performance
    • 8.3.2.3. Service Benchmarking
    • 8.3.2.4. Strategic Initiatives
  • 8.3.3. Albany Molecular Research (Curia)
    • 8.3.3.1. Company Overview
    • 8.3.3.2. Financial Performance
    • 8.3.3.3. Service Benchmarking
    • 8.3.3.4. Strategic Initiatives
  • 8.3.4. Merck & Co., Inc.
    • 8.3.4.1. Company Overview
    • 8.3.4.2. Financial Performance
    • 8.3.4.3. Service Benchmarking
    • 8.3.4.4. Strategic Initiatives
  • 8.3.5. QIAGEN
    • 8.3.5.1. Company Overview
    • 8.3.5.2. Financial Performance
    • 8.3.5.3. Service Benchmarking
    • 8.3.5.4. Strategic Initiatives
  • 8.3.6. Eurofins
    • 8.3.6.1. Company Overview
    • 8.3.6.2. Financial Performance
    • 8.3.6.3. Service Benchmarking
    • 8.3.6.4. Strategic Initiatives
  • 8.3.7. Evotec
    • 8.3.7.1. Company Overview
    • 8.3.7.2. Financial Performance
    • 8.3.7.3. Service Benchmarking
    • 8.3.7.4. Strategic Initiatives
  • 8.3.8. GenScript Biotech
    • 8.3.8.1. Company Overview
    • 8.3.8.2. Financial Performance
    • 8.3.8.3. Service Benchmarking
    • 8.3.8.4. Strategic Initiatives
  • 8.3.9. Pharmaron
    • 8.3.9.1. Company Overview
    • 8.3.9.2. Financial Performance
    • 8.3.9.3. Service Benchmarking
    • 8.3.9.4. Strategic Initiatives
  • 8.3.10. Syngene International
    • 8.3.10.1. Company Overview
    • 8.3.10.2. Financial Performance
    • 8.3.10.3. Service Benchmarking
    • 8.3.10.4. Strategic Initiatives
  • 8.3.11. Dalton Pharma Services
    • 8.3.11.1. Company Overview
    • 8.3.11.2. Financial Performance
    • 8.3.11.3. Service Benchmarking
    • 8.3.11.4. Strategic Initiatives
  • 8.3.12. Oncodesign
    • 8.3.12.1. Company Overview
    • 8.3.12.2. Financial Performance
    • 8.3.12.3. Service Benchmarking
    • 8.3.12.4. Strategic Initiatives
  • 8.3.13. Jubilant Biosys
    • 8.3.13.1. Company Overview
    • 8.3.13.2. Financial Performance
    • 8.3.13.3. Service Benchmarking
    • 8.3.13.4. Strategic Initiatives
  • 8.3.14. Domainex
    • 8.3.14.1. Company Overview
    • 8.3.14.2. Financial Performance
    • 8.3.14.3. Service Benchmarking
    • 8.3.14.4. Strategic Initiatives
  • 8.3.15. Dr. Reddy Laboratories Ltd.
    • 8.3.15.1. Company Overview
    • 8.3.15.2. Financial Performance
    • 8.3.15.3. Service Benchmarking
    • 8.3.15.4. Strategic Initiatives
  • 8.3.16. Pharmaron Beijing Co., Ltd.
    • 8.3.16.1. Company Overview
    • 8.3.16.2. Financial Performance
    • 8.3.16.3. Service Benchmarking
    • 8.3.16.4. Strategic Initiatives
  • 8.3.17. TCG Lifesciences Pvt Ltd.
    • 8.3.17.1. Company Overview
    • 8.3.17.2. Financial Performance
    • 8.3.17.3. Service Benchmarking
    • 8.3.17.4. Strategic Initiatives

Chapter 9. Key Recommendations

List of Tables

• Table 1 List of Tables
• Table 2 List of Secondary Sources
• Table 3 List of Abbreviations
• Table 4 U.S. Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
• Table 5 U.S. Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
• Table 6 U.S. Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
• Table 7 U.S. Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information procurement
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Market formulation & validation
• Fig. 6 Commodity flow analysis
• Fig. 7 Value-chain-based sizing & forecasting
• Fig. 8 QFD model sizing & forecasting
• Fig. 9 Bottom-up approach
• Fig. 10 Market snapshot
• Fig. 11 Segment snapshot 1
• Fig. 12 Segment snapshot 2
• Fig. 13 Competitive landscape snapshot
• Fig. 14 Parent market outlook, 2024 (USD Billion)
• Fig. 15 Ancillary market outlook, 2024 (USD Billion)
• Fig. 16 U.S. small molecule drug discovery outsourcing market dynamics
• Fig. 17 Porter's five forces analysis
• Fig. 18 PESTEL analysis
• Fig. 19 U.S. Small molecule drug discovery outsourcing market: workflow outlook and key takeaways
• Fig. 20 U.S. small molecule drug discovery outsourcing market: workflow movement analysis
• Fig. 21 Target identification & screening market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 22 Target validation & functional informatics market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 23 Lead identification & candidate optimization market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 24 Preclinical development market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 25 Other market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 26 U.S. small molecule drug discovery outsourcing market: Service outlook and key takeaways
• Fig. 27 U.S. small molecule drug discovery outsourcing market: Service movement analysis
• Fig. 28 Chemistry services market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 29 Biology services market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 30 U.S. small molecule drug discovery outsourcing market: therapeutics area outlook and key takeaways
• Fig. 31 U.S. small molecule drug discovery outsourcing market: therapeutics area movement analysis
• Fig. 32 Respiratory system market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 33 Pain and anesthesia market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 34 Oncology market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 35 Ophthalmology market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 36 Hematology market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 37 Cardiovascular market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 38 Endocrine market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 39 Gastrointestinal market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 40 Immunomodulation market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 41 Anti-infective market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 42 Central nervous system market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 43 Dermatology market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 44 Genitourinary system market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 45 U.S. small molecule drug discovery outsourcing market: End use outlook and key takeaways
• Fig. 46 U.S. small molecule drug discovery outsourcing market: End use movement analysis
• Fig. 47 Pharmaceutical & biotechnology companies market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 48 Academic institutes market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 49 Key company categorization
• Fig. 50 Service heat map analysis
• Fig. 51 Strategic framework